anorexia

Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival

...enia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients reported at least one episode of grade 4toxicity; the most common grade 4 toxicities were thrombocytopenia(5%) and neutropenia (3%). Fifty percent of patients reportedse...

Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma

...enia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients reported at least one episode of grade 4toxicity; the most common grade 4 toxicities were thrombocytopenia(5%) and neutropenia (3%). Fifty percent of patients reportedse...

Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients

...enia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients reported at least one episode of grade 4toxicity; the most common grade 4 toxicities were thrombocytopenia(5%) and neutropenia (3%). Fifty percent of patients reportedse...

Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop

...enia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients reported at least one episode of grade 4toxicity; the most common grade 4 toxicities were thrombocytopenia(5%) and neutropenia (3%). Fifty percent of patients reportedse...

New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma

...enia (36%), appetite decrease, including reportsof anorexia (36%), pyrexia (34%), vomiting (33%) and anemia (29%).Twenty percent of patients reported at least one episode of grade 4toxicity; the most common grade 4 toxicities were thrombocytopenia(5%) and neutropenia (3%). Fifty percent of patients reportedse...

Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)

...), asthenia (18%),pruritus (17%), back pain (17%), anorexia (15%), arthralgia (14%)and upper respiratory tract... (48%), pain (48%), edema(47%), hypotension (36%), anorexia (36%), and rash (34%). Post Marketing The following adverse reactions have been identified during ...

Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

...; nausea (84%); vomiting (58%);constipation (44%); anorexia (35%); stomatitis/pharyngitis (28%);diarrhea (26%)...ant adverse events (all grades)were fatigue (87%); anorexia (62%); nausea (39%); constipation(30%); vomiting (25%); diarrhea (21%); stomatitis/pharyngitis(20%);...

New Pfizer Oncology Data Across Numerous Cancer Types to be Presented at ASCO

...d-footsyndrome, skin discoloration, altered taste, anorexia andbleeding. For more information on Sutent and Pfizer Oncology please visitwww.pfizer.com. DISCLOSURE NOTICE: The information contained in this release isas of May 29, 2007. Pfizer assumes no obligation to update anyforward-looking statements cont...

Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection

...enia(36%), appetite decrease, including reports of anorexia (36%),pyrexia (34%), vomiting (33%) and anemia (29%). Twenty percent ofpatients reported at least one episode of grade 4 toxicity; themost common grade 4 toxicities were thrombocytopenia (5%) andneutropenia (3%). Fifty percent of patients reported se...